JP2011157405A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011157405A5 JP2011157405A5 JP2011116395A JP2011116395A JP2011157405A5 JP 2011157405 A5 JP2011157405 A5 JP 2011157405A5 JP 2011116395 A JP2011116395 A JP 2011116395A JP 2011116395 A JP2011116395 A JP 2011116395A JP 2011157405 A5 JP2011157405 A5 JP 2011157405A5
- Authority
- JP
- Japan
- Prior art keywords
- dry powder
- powder formulation
- surface modifier
- formulation
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 239000000843 powder Substances 0.000 claims 9
- 239000003607 modifier Substances 0.000 claims 7
- 239000000443 aerosol Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 230000002685 pulmonary effect Effects 0.000 claims 3
- 229940112141 dry powder inhaler Drugs 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229940071648 metered dose inhaler Drugs 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229940124630 bronchodilator Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- 125000000647 trehalose group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37732702P | 2002-05-02 | 2002-05-02 | |
| US60/377,327 | 2002-05-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004500839A Division JP2005535581A (ja) | 2002-05-02 | 2003-05-01 | 肺感染の拡大を制限する処方物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011157405A JP2011157405A (ja) | 2011-08-18 |
| JP2011157405A5 true JP2011157405A5 (https=) | 2012-09-13 |
Family
ID=29401482
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004500839A Pending JP2005535581A (ja) | 2002-05-02 | 2003-05-01 | 肺感染の拡大を制限する処方物 |
| JP2011116395A Pending JP2011157405A (ja) | 2002-05-02 | 2011-05-24 | 肺感染の拡大を制限する処方物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004500839A Pending JP2005535581A (ja) | 2002-05-02 | 2003-05-01 | 肺感染の拡大を制限する処方物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8858917B2 (https=) |
| EP (1) | EP1531795A4 (https=) |
| JP (2) | JP2005535581A (https=) |
| AU (1) | AU2003243191B2 (https=) |
| CA (1) | CA2483917C (https=) |
| WO (1) | WO2003092654A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003243191B2 (en) | 2002-05-02 | 2007-09-20 | President And Fellows Of Harvard College | Formulations limiting spread of pulmonary infections |
| GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20050207983A1 (en) | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
| EP2402001A1 (en) * | 2005-05-18 | 2012-01-04 | Pulmatrix, Inc. | Formulations for alteration of biophysical properties of mucosal lining |
| US20100172845A1 (en) * | 2007-05-29 | 2010-07-08 | Board Of Regents Of The University Of Texas System | Compositions and methods for treating mycobacterial infections |
| CA2754670A1 (en) * | 2009-03-26 | 2010-09-30 | Pulmatrix, Inc. | Anti-influenza formulations and methods |
| EP2464346A1 (en) | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| JP5909745B2 (ja) | 2010-11-12 | 2016-04-27 | クール ファーマシューティカルズ ディベロップメント カンパニー | 炎症性疾患の治療薬、ならびにウイルスまたは細菌感染疾患の治療薬 |
| US9693990B2 (en) | 2011-10-14 | 2017-07-04 | The Trustees Of The Stevens Institute Of Technology | Use of rhodamine dyes to reduce alveolar surface tension |
| US9504796B2 (en) * | 2011-10-14 | 2016-11-29 | The Trustees Of The Stevens Institute Of Technology | Reducing ventilator-induced lung injury |
| CN107596518B (zh) | 2012-02-29 | 2021-04-23 | 普马特里克斯营业公司 | 可吸入干粉剂 |
| JP5478693B2 (ja) * | 2012-03-23 | 2014-04-23 | 太平洋セメント株式会社 | 二次電池用正極活物質及びその製造方法 |
| WO2013192532A2 (en) | 2012-06-21 | 2013-12-27 | Northwestern University | Peptide conjugated particles |
| CN105263476A (zh) | 2013-03-13 | 2016-01-20 | 库尔制药开发公司 | 用于治疗炎症的免疫修饰性颗粒 |
| IL292567B2 (en) | 2013-08-13 | 2025-06-01 | Univ Northwestern | Peptide conjugated particles |
| US10391151B2 (en) | 2015-06-29 | 2019-08-27 | The Trustees Of The Stevens Institute Of Technology | Dilute surfactant or isolated surfactant protein solution for the reduction of surface tension in the lung |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US37053A (en) | 1862-12-02 | Improved me at-cutter | ||
| DE3229179C2 (de) * | 1982-08-05 | 1986-04-17 | A. Nattermann & Cie GmbH, 5000 Köln | Lungensurfactant |
| US4899914A (en) | 1988-11-04 | 1990-02-13 | Ciba-Geigy Corporation | Method for producing a sterile preservative-free aerosol saline solution |
| US5230884A (en) | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
| US5175152A (en) | 1990-09-28 | 1992-12-29 | Singh Nikhilesh N | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| US5466680A (en) * | 1992-03-26 | 1995-11-14 | Cytologics, Inc. | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| JP3961029B2 (ja) | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
| US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
| US5514665A (en) * | 1993-12-30 | 1996-05-07 | University Of British Columbia | Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| AUPM411494A0 (en) * | 1994-02-25 | 1994-03-24 | Central Sydney Area Health Service | Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum |
| US5633003A (en) * | 1994-03-31 | 1997-05-27 | Cantor; Jerome O. | Use of intratracheally administered hyaluronic acid to ameliorate emphysema |
| CA2145948A1 (en) * | 1994-04-06 | 1995-10-07 | Wendell A. Ehrhart | Floor covering having a (meth)acrylated, highly ethoxylated, aromatic polyester wear layer |
| US5863563A (en) | 1994-10-20 | 1999-01-26 | Alphagene Inc. | Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| WO1996026726A1 (en) * | 1995-02-28 | 1996-09-06 | Hoechst Marion Roussel, Inc. | Pharmaceutical composition for piperidinoalkanol compounds |
| US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
| US5628984A (en) | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| WO1997029738A1 (en) * | 1996-02-16 | 1997-08-21 | The Administrators Of The Tulane Educational Fund | Methods and compositions for treating eustachian tube dysfunction by inhalation |
| GB9606677D0 (en) | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
| US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
| US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| DE19653969A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE69732306T2 (de) * | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| US6339075B1 (en) * | 1997-06-30 | 2002-01-15 | The University Of British Columbia | Use of dextran and other polysaccharides to improve mucus clearance |
| US5883084A (en) | 1998-06-08 | 1999-03-16 | Clarion Pharmaceuticals Inc. | Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine |
| JP2004513071A (ja) * | 2000-05-23 | 2004-04-30 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 肺の弾性繊維損傷に関連した呼吸器疾患の治療方法 |
| US6669959B1 (en) * | 2000-07-18 | 2003-12-30 | Aeropharm Technology Incorporated | Modulated release particles for lung delivery |
| AU2001278131A1 (en) | 2000-08-01 | 2002-02-13 | Shofner Engineering Associates, Inc. | Generation, delivery, measurement and control of aerosol boli for diagnostics and treatments of the respiratory/pulmonary tract of a patient |
| CA2432319A1 (en) | 2000-12-21 | 2002-07-18 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
| AU2003243191B2 (en) | 2002-05-02 | 2007-09-20 | President And Fellows Of Harvard College | Formulations limiting spread of pulmonary infections |
| EP1503744A1 (en) | 2002-05-13 | 2005-02-09 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
| US20050207983A1 (en) * | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
| CA2602596A1 (en) * | 2004-03-30 | 2005-10-13 | Malcolm King | Compositions and methods for improved mucus function |
| US8627821B2 (en) * | 2005-01-10 | 2014-01-14 | Pulmatrix, Inc. | Method and device for decreasing contamination |
| US9708895B2 (en) | 2013-05-07 | 2017-07-18 | Halliburton Energy Services, Inc. | Intrawell fluid injection system and method |
-
2003
- 2003-05-01 AU AU2003243191A patent/AU2003243191B2/en not_active Ceased
- 2003-05-01 CA CA2483917A patent/CA2483917C/en not_active Expired - Fee Related
- 2003-05-01 WO PCT/US2003/013707 patent/WO2003092654A1/en not_active Ceased
- 2003-05-01 JP JP2004500839A patent/JP2005535581A/ja active Pending
- 2003-05-01 EP EP03747647A patent/EP1531795A4/en not_active Withdrawn
-
2009
- 2009-01-09 US US12/351,328 patent/US8858917B2/en not_active Expired - Fee Related
-
2011
- 2011-05-24 JP JP2011116395A patent/JP2011157405A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011157405A5 (https=) | ||
| JP2011116788A5 (https=) | ||
| Weber et al. | Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art | |
| Zhang et al. | Formation, characterization, and fate of inhaled drug nanoparticles | |
| Tan et al. | Novel approaches for the treatment of pulmonary tuberculosis | |
| JP2014526447A5 (https=) | ||
| JP2020527377A5 (https=) | ||
| JP2015519403A5 (https=) | ||
| JP2013544781A5 (https=) | ||
| JP2016512494A5 (https=) | ||
| AU2018253545A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| JP2013534227A5 (https=) | ||
| JP2012503668A5 (https=) | ||
| JP2010537989A5 (https=) | ||
| WO2007123793A3 (en) | Swellable particles for drug delivery | |
| JP2014509313A5 (https=) | ||
| JP2019151649A5 (https=) | ||
| WO2010138884A3 (en) | Respiratory delivery of active agents | |
| JP2015509788A5 (https=) | ||
| JP2009512663A5 (https=) | ||
| WO2013038267A8 (en) | Tamper resistant pharmaceutical formulations | |
| JP2012131827A5 (https=) | ||
| WO2011005421A3 (en) | Use of nanocrystals for a drug delivery balloon | |
| WO2012051426A3 (en) | Aggregate nanoparticulate medicament formulations, manufacture and use thereof | |
| HRP20230863T1 (hr) | Inhalacijska formulacija rapamicina, namijenjena liječenju stanja povezanih sa starenjem |